en · de · es · fr · pt
creatine-notes.peptides6908.com › News › Mechanism And Pharmacokinetics — What the Evidence Shows

Mechanism And Pharmacokinetics — What the Evidence Shows

By Editorial Desk · published 2025-11-23 · last reviewed 2025-12-19 · News

If you have been reading about GHRH analogue and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2025-12-19. Numbers and descriptions here follow the published literature rather than marketing material.

Mechanism and Pharmacokinetics

Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

Receptor Action and Pharmacokinetics

Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.

CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.

Cjc-1295 at a glance

PropertyValueNotes
Target receptorGHRH receptor (GHRHR)Expressed on pituitary somatotrophs
Primary actionStimulates growth hormone releaseAmplifies pulse size
Half-life, albumin-binding formSeveral days as reportedSlow release from albumin complex
Half-life, unmodified analogAbout 30 minutes in animal estimatesCleared by proteases and filtration
Common analytical approachLC-MS/MS for peptide, immunoassay for hormonesMethods answer different questions

Molecular Background and Naming

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Related pages on this site

Structure And Receptor Pharmacology

Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.

CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.

CJC-1295 Structure And Mechanism

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

Background from the literature

Ag+ + BH4− + 3 H2O → Ag0 +B(OH)3 +3.5 H2 The reduced metal atoms will form nanoparticle nuclei. Overall, this process is similar to the above reduction method using citrate. The benefit of using sodium borohydride is increased monodispersity of the final particle population. The reason for the increased monodispersity when using NaBH4 is that it is a stronger reducing agent than citrate. The impact of reducing agent strength can be seen by inspecting a LaMer diagram which describes the nucleation and growth of nanoparticles. When silver nitrate (AgNO3) is reduced by a weak reducing agent like citrate, the reduction rate is lower which means that new nuclei are forming and old nuclei are growing concurrently. This is the reason that the citrate reaction has low monodispersity. Because NaBH4 is a much stronger reducing agent, the concentration of silver nitrate is reduced rapidly which shortens the time during which new nuclei form and grow concurrently yielding a monodispersed population of silver nanoparticles. Particles formed by reduction must have their surfaces stabilized to prevent undesirable particle agglomeration (when multiple particles bond together), growth, or coarsening. The driving force for these phenomena is the minimization of surface energy (nanoparticles have a large surface to volume ratio).

Sunak announces a further £2.5bn in military aid for Ukraine during 2024. British Post Office scandal: The BBC reports that Post Office managers threatened and lied to the broadcaster in an attempt to conceal key evidence ahead of the broadcast of the 2015 Panorama documentary that brought the Horizon IT scandal to public attention. Financial experts estimate the Post Office may have underpaid £100m in tax because of how it declared compensation payments to victims of the Horizon IT scandal. 13 January Thousands of people join a pro-Palestinian march in London calling for a ceasefire in Gaza due to the ongoing Gaza war. A fleet of electric buses are withdrawn in South London after a fire starts on the 200 hybrid electric bus on 11 January. A new biography of King Charles III by Daily Mail royal correspondent Robert Hardman says that a memo written by Queen Elizabeth II's private secretary, Sir Edward Young, reports that the Queen's final moments in September 2022 were "very peaceful". Five cross-Channel migrants, the first seen in 2024, arrive in a Border Force boat in Kent after being picked up while crossing from France. 14 January Five people die when a small boat overturns in French waters as around 70 people try to board it in an attempt to migrate across the English Channel to the UK. Thousands of people attend a pro-Israel rally in London to mark 100 days since the 7 October attack and call for the release of all hostages from Gaza. Six people are arrested over a plot by the protest group Palestine Action to disrupt the London Stock Exchange.

Inflammatory conditions of the lung tissue are pneumonia, of the respiratory tract are bronchitis and bronchiolitis, and of the pleurae surrounding the lungs pleurisy. Inflammation is usually caused by infections due to bacteria or viruses. When the lung tissue is inflamed due to other causes it is called pneumonitis. One major cause of bacterial pneumonia is tuberculosis. Chronic infections often occur in those with immunodeficiency and can include a fungal infection by Aspergillus fumigatus that can lead to an aspergilloma forming in the lung. In the US certain species of rat can transmit a hantavirus to humans that can cause untreatable hantavirus pulmonary syndrome with a similar presentation to that of acute respiratory distress syndrome (ARDS). Alcohol affects the lungs and can cause inflammatory alcoholic lung disease. Acute exposure to alcohol stimulates the beating of cilia in the respiratory epithelium. However, chronic exposure has the effect of desensitising the ciliary response which reduces mucociliary clearance (MCC). MCC is an innate defense system protecting against pollutants and pathogens, and when this is disrupted the numbers of alveolar macrophages are decreased. A subsequent inflammatory response is the release of cytokines. Another consequence is the susceptibility to infection.

The "inert" or noble gas elements (helium, neon, argon, krypton, xenon and radon) are composed of lone atoms as their smallest discrete unit, but the other isolated chemical elements consist of either molecules or networks of atoms bonded to each other in some way. Identifiable molecules compose familiar substances such as water, air, and many organic compounds like alcohol, sugar, gasoline, and the various pharmaceuticals. However, not all substances or chemical compounds consist of discrete molecules, and indeed most of the solid substances that make up the solid crust, mantle, and core of the Earth are chemical compounds without molecules. These other types of substances, such as ionic compounds and network solids, are organized in such a way as to lack the existence of identifiable molecules per se. Instead, these substances are discussed in terms of formula units or unit cells as the smallest repeating structure within the substance. Examples of such substances are mineral salts (such as table salt), solids like carbon and diamond, metals, and familiar silica and silicate minerals such as quartz and granite. One of the main characteristics of a molecule is its geometry often called its structure. While the structure of diatomic, triatomic or tetra-atomic molecules may be trivial, (linear, angular pyramidal etc.) the structure of polyatomic molecules, that are constituted of more than six atoms (of several elements) can be crucial for its chemical nature.

== Reduction and alkylation (R & A) == The staining and destaining of gels is often followed by the reduction and alkylation (r&a) of the cystines or cysteines in the proteins. Hereby, the disulfide bonds of the proteins are irreversibly broken up and the optimal unfolding of the tertiary structure is obtained. The reduction to the thiol is accomplished by the reaction with chemicals containing sulfhydryl or phosphine groups such as dithiothreitol (DTT) or tris-2-carboxyethylphosphine hydrochloride (TCEP). In course of the subsequent irreversible alkylation of the SH groups with iodoacetamide the cysteines are transformed to the stable S-carboxyamidomethylcysteine (CAM; adduct: -CH2-CONH2). The molecular weight of the cysteine amino-acid residue is thereby increased from 103.01 Da to 160.03 Da. Reduction and alkylation of cysteine residues improves peptide yield and sequence coverage and the identification of proteins with a high number of disulfide bonds. Due to the rareness of the amino acid cysteine for most of the proteins the step of r&a does not effect any improvement of the mass spectrometric analysis. For the quantitative and homogeneous alkylation of cysteines the position of the modification step in the sample-preparation process is crucial. With denaturing electrophoresis it is strongly recommended to perform the reaction before the execution of the electrophoresis, since there are free acrylamide monomers in the gel able to modify cysteine residues irreversibly. The resulting acrylamide adducts have a molecular weight of 174.05 Da.

Sources: en.wikipedia.org

Further detail

A trachea may be narrowed or compressed, usually a result of enlarged nearby lymph nodes; cancers of the trachea or nearby structures; large thyroid goitres; or rarely as a result of other processes such as unusually swollen blood vessels. Scarring from tracheobronchial injury or intubation; or inflammation associated with granulomatosis with polyangiitis may also cause a narrowing of the trachea (tracheal stenosis). Obstruction invariably causes a harsh breathing sound known as stridor. A camera inserted via the mouth down into the trachea, called bronchoscopy, may be performed to investigate the cause of an obstruction. Management of obstructions depends on the cause. Obstructions as a result of malignancy may be managed with surgery, chemotherapy or radiotherapy. A stent may be inserted over the obstruction. Benign lesions, such as narrowing resulting from scarring, are likely to be surgically excised. One cause of narrowing is tracheomalacia, which is the tendency for the trachea to collapse when there is increased external pressure, such as when airflow is increased during breathing in or out, due to decreased compliance. It can be due to congenital causes, or due to things that develop after birth, such as compression from nearby masses or swelling, or trauma. Congenital tracheomalacia can occur by itself or in association with other abnormalities such as bronchomalacia or laryngomalacia, and abnormal connections between the trachea and the oesophagus, amongst others.

There are hydrophobic amino acids and hydrophilic amino acids in protein molecules. After protein folding in aqueous solution, hydrophobic amino acids usually form protected hydrophobic areas while hydrophilic amino acids interact with the molecules of solvation and allow proteins to form hydrogen bonds with the surrounding water molecules. If enough of the protein surface is hydrophilic, the protein can be dissolved in water. When salt is added to the solution, there is more frequent interaction between solvent molecules and salt ions. As a result, the protein and salt ions compete to interact with the solvent molecules with the result that there are fewer solvent molecules available for interaction with the protein molecules than before. The protein–protein interactions thus become stronger than the solvent–solute interactions and the protein molecules associate by forming hydrophobic interactions with each other. After dissociation in a given solvent, the negatively charged atoms from a chosen salt begin to compete for interactions with positively charged molecules present in the solution. Similarly, the positively charged cations compete for interactions with the negatively charged molecules of the solvent. This process is known as salting out. Soaps are easily precipitated by concentrated salt solution, the metal ion in the salt reacts with the fatty acids forming back the soap and glycerin (glycerol). To separate glycerin from the soap, the pasty boiling mass is treated with brine (NaCl solution).

In biochemistry, biomolecular condensates are a class of membrane-less organelles and organelle subdomains, which carry out specialized functions within the cell. Unlike many organelles, biomolecular condensate composition is not controlled by a bounding membrane. Instead, condensates can form and maintain organization through a range of different processes. The most well-known process is phase separation of proteins, RNA, and other biopolymers into either colloidal emulsions, gels, liquid crystals, solid crystals, or protein aggregates within cells.

49 Squadron RAF in October 1956 in Operation Buffalo at Maralinga; Project Dazzle and its research on re-entry vehicles enabled the Mercury-Atlas 6 launch to happen in February 1962; the Australian government built four launch pads for the Blue Streak in 1959, but it was cancelled in 1960, the redesignated satellite launcher Blue Streak first launched on 5 June 1964, and satellites would be launched by 1966, but only WRESAT was launched in November 1967, on a Redstone rocket instead; Woomera launched over 4000 missiles and cost the Australian government £900m; the site was demolished by the Australian government at the end of the 1960s; part of the former site is now the secret Joint Defense Facility Nurrungar 17 September Not in the Stars, making mathematical models for predictions; Robert May, Baron May of Oxford of Imperial College; William Phillips and his 1949 MONIAC economic model; a British Airways 747 flight simulator; computer models of epidemics - the R number, and vaccination policies; the UK fishing industry had quotas imposed in 1983, due to mathematical models of fish stocks; John Shepherd of the Centre for Environment, Fisheries and Aquaculture Science (CEFAS) laboratory in Lowestoft; computer models of warfare were developed by the Defence Operational Analysis Establishment in West Byfleet with deputy director David Faddy, which closed six years later, superseded in function by CORDA (UK); Irving Mintzer of the World Resources Institute; the NASA Goddard Space Flight Center had developed computer models of the Earth's atmosphere, such as rainfall; the hole in the Ozone layer and phytoplankton, with Norman Myers; Ian Riley of the Economist Intelligence Unit. Narrated by Bob Peck. Written, produced and directed by Chris Haws, made by InCA 24 September Race for the Top, CERN versus Fermilab; in 1983 CERN discovered the W and Z bosons, it and Fermilab were looking for the top quark; Leon M. Lederman, director of Fermilab; Andy Parker of CERN; CERN had 80 scientists led by Luigi Di Lella on its UA2 experiment, and Fermilab had its Collider Detector at Fermilab (CDF); Roy Schwitters; Fermilab had discovered the bottom quark in 1977; John Ellis of CERN; each team prepared for an annual physics conference at La Thuile, Aosta Valley in north-west Italy; UA2 had a meeting in July 1989 in Cambridge; the top quark would be discovered in 1995 with 175 GeV by Fermilab. Narrated by Carole Boyd, known for playing Lynda Snell in The Archers, joint production InCA and WGBH 1 October Walk on Wheels, a half-million disabled people have a wheelchair in the UK; NHS wheelchairs were made by Carter's; the quick-release axle was developed in World War II, for releasing munitions; the residential Treloar School in Alton, Hampshire, which was funded by individual LEAs, with charity funding as well; Bill Walmsley of the Department of Health's wheelchair research centre in Blackpool, now part of the Disability and Carers Service at DWP Peel Park at the end of the M55 motorway, on the A5230 in Westby-with-Plumptons. Narrated by John Hedges, produced by Jeremy Llewellyn-Jones, made by Chrysalis Television (North One Television) 8 October Invasion of the Body Scanners, a reference to the 1956 film Invasion of the Body Snatchers; X-rays were introduced in the 1890s, but it took fifty years to vastly improve the early crude techniques; CT was invented in the late 1960s - its inventor with Prince Philip, Duke of Edinburgh; Ian McDougall at a magnet technology company, who designed the first magnet, cooled with liquid helium in 1979; X-ray scans were a fairly crude process, but other types required computer image processing; Michael Boswell of GE Medical Systems; scans were taken in the coronal plane and sagittal plane; by 1989 the NHS only had four of these scanners - one was at Frenchay Hospital, made by GEC Medical (Picker International) - there were around 25 scanners in the whole UK; the Brockton Hospital; there were 1500 scanners in the US, with 39 in Massachusetts; Donald Longmore of the National Heart and Chest Hospitals, who performed the UK's first heart transplant on 3 May 1968; CT scanning had been performed for neuroradiology since the mid-1970s; radiology at Middlesex Hospital; medical ultrasound was a much safer technique than X-rays, and a new type deployed the Doppler effect, but medical ultrasound lacked cast-iron image definition; but scanners were hideously expensive, due to the convoluted enormous magnets that were required. Narrated by John Benson, produced by Mike Johnstone, directed by Ed Newstead, made by VATV (Video Arts) 15 October Wheels of War, about the early 1990s Leyland 4-tonne truck and defence procurement; James Adams, journalist; military historian Correlli Barnett; general service (GS) cargo vehicles, and a RE vehicle carrying a Medium Girder Bridge; a youthful-looking Mark Francois; the Austin Champ, designed in the 1950s; the British Aerospace Nimrod AEW3 was cancelled in 1986 at a cost of £860m; cost-plus contracts were replaced by competitive; Sir Peter Levine was brought in as Chief of Defence Procurement; the Leyland 4-tonne truck would replace the Bedford MK, made by Bedford Vehicles; journalist John Parsons; each vehicle would cost around £23,000 each; the Leyland 5-tonne was developed from its Comet and Roadrunner vehicles (developed into the DAF LF) under project director Stuart Hayes; the equivalent German vehicle, the MAN KAT1, had cost £75,000 each; the Panavia Tornado; Leyland design engineer Colin Ingram; the three vehicle prototypes were punishingly tested at the Royal Armament Research and Development Establishment (RARDE). Narrated by Anthony Valentine, produced by Patrick Uden made by Uden Associates 22 October Three Score Years and Then? 29 October Robotopia, advances of robotics in Japan, and bizarre contraptions; Frederik L. Schodt, author of the 1988 book Inside the Robot Kingdom - for hundreds of years until 1853, Japan was a fairly backward country; Joseph Engelberger, who developed the first industrial robot, Unimate, made by his company Unimation from 1961 - there were around 200,000 industrial robots, with around 130,000 of those in Japan; Japanese robot artist Hajime Sorayama, who drew lurid female robots; automated mannequins; nineteen universities in Japan were developing ungainly humanoid robots, notably Ichiro Kato at Waseda University; Seiuemon Inaba of FANUC, produced by Mike Wallington, made by Kai Productions 5 November Fly-by-wire, the new Airbus 320; software engineer Mike Hennell of the University of Liverpool; Roger Beteille, managing director of Airbus from 1967–85, and Henri Ziegler; John Knight of the University of Virginia; software engineer Bev Littlewood of City University; the A320 was the first fly-by-wire airliner; Blind Landing Experimental Unit testing at RAE Bedford in the 1960s, and developing the automatic pilot with a Vickers Valetta; testing Concorde in a wind tunnel; the Apollo project had depended on computers - it couldn't be done otherwise; Paul Ceruzzi of the Air and Space Museum; Philip Felleman of the Draper Laboratory; testing the F-16 in the early 1970s; Joe Sutter, head of Boeing from 1981–86; Boeing introduced flight management systems, so not needing a flight engineer; David Learmount of Flight International, and how Airbus had more commercial need to be innovative; the A300 was the first two-engined wide body aircraft; the A310 had electrical hydraulics and electronic control of some flight surfaces; John Cullyer of the University of Warwick; the A320 had five master computers; Gordon Corps, the Airbus test pilot, later to fly on Thai Airways International Flight 311 in 1992; Gilles Pichon, chief engineer of the A320; Jacques Troyes, head of Flight Control at Airbus; there was emergency mechanical control to the rudder and tail trim; the June 1988 Air France Flight 296Q - Michel Asseline, the pilot, said the aircraft had tried to land, when he tried to raise the aircraft; Alain Monnier of the DGAC said it was pilot error; Greg Holt of the FAA and Brian Perry of the CAA; the four-engined A330 would be manufactured from 1992; a prototype fly-by-wire relaxed stability Saab JAS 39 Gripen tumbles on 2 February 1989 at Linköping/Saab Airport, piloted by Lars Rådeström. Narrated by James Bellini, produced by Ben Shephard (historian), directed by John Longley, made by Box Television with WGBH 12 November Deadly Force, aerial shots of Miami; the WINZ Miami broadcaster; the Miami SWAT response team; the 1980 Miami riots; Sgt Louis Battle, Bernie Gonzalez and the Heckler & Koch MP5; Tom Salerno and the Remington Model 870 pump action shotgun, the M1911 pistol and Beretta M9; Ted Bradley; a WSVN news broadcast with Jane Akre; two thirds of Miami's population were Latin-American, and had many exiled citizens; the 1980 Mariel boatlift, from Cuba, added to the population and much to the crime; Miami had two murders a day in the 1980s; Robert Waller; Edna Buchanan of the Miami Herald; severed limbs washed up on Miami beach; the Colt Python; the Beretta 92; the Colt AR-15 semi-automatic rifle; 80% of SWAT call-outs were connected to the drug trade; two thirds of illegal drugs went through Miami; Sgt Louis Philips and negotiation techniques; SWAT negotiator Eric Caspener; 95% of SWAT negotiations work. Produced by David Jones, directed by Catherine Bailey, made by Buffalo Pictures 19 November Faster than a Speeding Bullet, and the quest for supersonic flight, eventually resulting in Concorde. The programme features former Concorde pilot Christopher Orlebar, who wrote The Concorde Story. The history of supersonic research dates back to the 18th Century, but supersonic flight only became achievable after the development of the jet engine. Featured aircraft include: the wartime Messerschmitt Me 262; the innovative de Havilland DH 108; the Messerschmitt Me 163 Komet; the Fairey Delta 2, the Bell X1 and numerous experimental "X Planes". After the war, the world's fastest non-experimental aircraft was the Lockheed SR-71 Blackbird, which could fly at 95,000 ft at 2,300 mph. The programme interviews key figures in the development of supersonic military aircraft and second generation SST (Supersonic Transport) aircraft. Narrated by Tony Anholt, written, produced and directed by Chris Haws, made by InCA

Sources: en.wikipedia.org

Frequently asked questions

How long does the albumin-binding form remain active?

Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.

What do researchers measure after administering the peptide?

Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.

Are the clinical effects well established?

Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.

How does CJC-1295 raise growth hormone levels?

It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.

Network